Orelabrutinib in the Treatment of Relapsed/Refractory AIHA

Clinical trial NCT07453368 · RECRUITING

Trial details

NCT number: NCT07453368
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Hemolytic Anemia (AIHA)

Start date: 2026-03-01
Primary completion: 2027-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.